Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report
Dabigatran is used for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is still unclear whether the use of dabigatran leads to more bleeding compared with warfarin. In this paper, we present a case of intraperitoneal hemorrhage in a 54-years-old ma...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2016-06-01
|
| Series: | Haseki Tıp Bülteni |
| Subjects: | |
| Online Access: | http://www.hasekidergisi.com/article_10730/Intraperitoneal-Hemorrhage-In-A-Peritoneal-Dialysis-Patient-Using-Dabigatran-A-Case-Report |
| _version_ | 1797905888767377408 |
|---|---|
| author | Egemen Cebeci Nilay Şengül Samancı Meltem Gürsu Abdullah Şumnu Serhat Karadağ Sami Uzun Emel Tatlı Ahmet Behlül Leyla Koç Zeki Aydın Savaş Öztürk |
| author_facet | Egemen Cebeci Nilay Şengül Samancı Meltem Gürsu Abdullah Şumnu Serhat Karadağ Sami Uzun Emel Tatlı Ahmet Behlül Leyla Koç Zeki Aydın Savaş Öztürk |
| author_sort | Egemen Cebeci |
| collection | DOAJ |
| description | Dabigatran is used for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is still unclear whether the use of dabigatran leads to more bleeding compared with warfarin. In this paper, we present a case of intraperitoneal hemorrhage in a 54-years-old male peritoneal dialysis patient using dabigatran for paroxysmal atrial fibrillation because international normalized ratio level could not be kept at target levels during follow-up. The use of dabigatran in atrial fibrillation has become widespread in recent years. Despite the low risk of intracranial hemorrhage, clinicians should be careful in patients with chronic kidney disease because coagulation monitoring is not possible. |
| first_indexed | 2024-04-10T10:12:24Z |
| format | Article |
| id | doaj.art-5f2b38dc184e44a0aa571344063f9829 |
| institution | Directory Open Access Journal |
| issn | 1302-0072 2147-2688 |
| language | English |
| last_indexed | 2024-04-10T10:12:24Z |
| publishDate | 2016-06-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Haseki Tıp Bülteni |
| spelling | doaj.art-5f2b38dc184e44a0aa571344063f98292023-02-15T16:22:05ZengGalenos YayineviHaseki Tıp Bülteni1302-00722147-26882016-06-0154211811910.4274/haseki.2922Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case ReportEgemen Cebeci0Nilay Şengül Samancı1Meltem Gürsu2Abdullah Şumnu3Serhat Karadağ4Sami Uzun5Emel Tatlı6Ahmet Behlül7Leyla Koç8Zeki Aydın9Savaş Öztürk10Haseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Internal Diseases, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyHaseki Training and Research Hospital, Clinic of Nephrology, İstanbul, TurkeyDabigatran is used for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is still unclear whether the use of dabigatran leads to more bleeding compared with warfarin. In this paper, we present a case of intraperitoneal hemorrhage in a 54-years-old male peritoneal dialysis patient using dabigatran for paroxysmal atrial fibrillation because international normalized ratio level could not be kept at target levels during follow-up. The use of dabigatran in atrial fibrillation has become widespread in recent years. Despite the low risk of intracranial hemorrhage, clinicians should be careful in patients with chronic kidney disease because coagulation monitoring is not possible.http://www.hasekidergisi.com/article_10730/Intraperitoneal-Hemorrhage-In-A-Peritoneal-Dialysis-Patient-Using-Dabigatran-A-Case-ReportDabigatranintraperitoneal hemorrhageperitoneal dialysis |
| spellingShingle | Egemen Cebeci Nilay Şengül Samancı Meltem Gürsu Abdullah Şumnu Serhat Karadağ Sami Uzun Emel Tatlı Ahmet Behlül Leyla Koç Zeki Aydın Savaş Öztürk Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report Haseki Tıp Bülteni Dabigatran intraperitoneal hemorrhage peritoneal dialysis |
| title | Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report |
| title_full | Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report |
| title_fullStr | Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report |
| title_full_unstemmed | Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report |
| title_short | Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report |
| title_sort | intraperitoneal hemorrhage in a peritoneal dialysis patient using dabigatran a case report |
| topic | Dabigatran intraperitoneal hemorrhage peritoneal dialysis |
| url | http://www.hasekidergisi.com/article_10730/Intraperitoneal-Hemorrhage-In-A-Peritoneal-Dialysis-Patient-Using-Dabigatran-A-Case-Report |
| work_keys_str_mv | AT egemencebeci intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT nilaysengulsamancı intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT meltemgursu intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT abdullahsumnu intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT serhatkaradag intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT samiuzun intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT emeltatlı intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT ahmetbehlul intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT leylakoc intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT zekiaydın intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport AT savasozturk intraperitonealhemorrhageinaperitonealdialysispatientusingdabigatranacasereport |